• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Platypnoea-orthodeoxia syndrome in COVID-19 pneumonia patients: An observational study

tetano

Editor, Senior Moderator
Respir Investig


. 2024 Jan 27;62(2):291-294.
doi: 10.1016/j.resinv.2024.01.006. Online ahead of print. Platypnoea-orthodeoxia syndrome in COVID-19 pneumonia patients: An observational study

Masatoshi Hanada[SUP] 1 [/SUP], Yuji Ishimatsu[SUP] 2 [/SUP], Noriho Sakamoto[SUP] 3 [/SUP], Nobuyuki Ashizawa[SUP] 4 [/SUP], Hirotomo Yamanashi[SUP] 5 [/SUP], Motohiro Sekino[SUP] 6 [/SUP], Koichi Izumikawa[SUP] 7 [/SUP], Hiroshi Mukae[SUP] 3 [/SUP], Koya Ariyoshi[SUP] 8 [/SUP], Takahiro Maeda[SUP] 9 [/SUP], Tetsuya Hara[SUP] 6 [/SUP], Shuntaro Sato[SUP] 10 [/SUP], Ryo Kozu[SUP] 1 [/SUP]



Affiliations
Abstract

This retrospective observational study aimed to assess the clinical characteristics of platypnea-orthodeoxia syndrome in patients with coronavirus disease 2019 (COVID-19) treated using mechanical ventilation or high-flow nasal canula. We analyzed 42 consecutive patients with COVID-19 from January 2020 to March 2022. The primary outcomes were the incidence of platypnea-orthodeoxia syndrome, the time with required long-term oxygen therapy, and short-term prognosis. Additionally, we examined the relationships between platypnea-orthodeoxia syndrome and COVID-19 severity, the time with long-term oxygen therapy, and short-term prognosis. Of the 42 included patients, 15 (35.7 %) had platypnea-orthodeoxia syndrome. Although mortality was not significantly different between both groups, the oxygen withdrawal rate in the platypnea-orthodeoxia syndrome group was significantly lower than that in the group without this syndrome. Clinical staff should be aware of the possibility of platypnea-orthodeoxia syndrome during positional changes in patients with COVID-19. Recognizing POS can improve early detection, countermeasures, and safety during physiotherapy.

Keywords: COVID-19; Physiotherapy; Platypnea-orthodeoxia syndrome; Positional change; Positional dyspnea.

 
Back
Top Bottom